Trial Profile
A Therapeutic Exploratory, Single Arm, Multicenter Trial to Evaluate the Efficacy and Safety of Levetiracetam up to 4000 mg/Day (500mg Oral Tablets) on Levodopa Induced Dyskinesias in Adults With Idiopathic Parkinson's Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Oct 2009
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Drug-induced dyskinesia
- Focus Therapeutic Use
- Sponsors UCB
- 16 Jul 2007 Status changed from in progress to completed
- 04 Dec 2005 New trial record.